Top Sell
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.82 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.01 | €6.49 | 540.227% |
| Evotec SE | 4 | 3 | 0 | 0 | €8.11 | €10.00 | 23.381% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Immuron | 0 | 1 | 0 | 0 | €2.30 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.21 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.11 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.59 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.99 | €2.00 | 102.593% |
| Compugen Ltd. | 5 | 2 | 0 | 0 | €1.60 | €3.69 | 130.350% |
| Bristol-Myers Squibb | 7 | 2 | 0 | 0 | €44.70 | €70.25 | 57.182% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €6.95 | €11.00 | 58.365% |
| Enlivex Therapeutics Ltd. | 1 | 1 | 0 | 0 | €1.22 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.25 | €50.00 | 3909.623% |
| Moleculin Biotech Inc | 3 | 23 | 0 | 0 | €0.41 | €18.42 | 4393.659% |
| CEL-SCI Corp. | 0 | 1 | 0 | 0 | €1.07 | - | - |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.12 | - | - |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.55 | €7.00 | 6.870% |
| Evoke Pharma Inc. | 0 | 24 | 0 | 0 | €0.38 | - | - |
| Glycomimetics Inc. | 5 | 3 | 0 | 0 | €0.20 | €7.35 | 3579.479% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 0 | €0.31 | €4.62 | 1370.719% |
| Bellicum Pharmaceuticals Inc. | 0 | 12 | 0 | 0 | €0.064 | - | - |
| Inventiva SA | 1 | 1 | 0 | 0 | €2.17 | €6.00 | 177.136% |